Jingyuan Du
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Bone health and treatments, Long-Term Effects of COVID-19, Drug-Induced Hepatotoxicity and Protection
Most-Cited Works
- → Incidence and risk factors of anti‐tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients(2021)74 cited
- → Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID‐19: A Large Case‐Control Study(2020)57 cited
- Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit.(2003)
- → Role of Drugs used for chronic disease management on Susceptibility and Severity of COVID-19: A Large Case-Control Study(2020)42 cited
- Basic fibroblast growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head.(2004)
- Effects of basic fibroblast growth factor on biological characteristics of osteoblasts.(2003)
- → Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival(2020)5 cited
- → Magnesium status, serum vitamin D concentration and mortality among congestive heart failure patients: a cohort study from NHANES 2007–2018(2024)4 cited
- → PS-098-Prevalence and risk factors of first line anti-tuberculosis drug induced liver injury: Large cohort study involving 4652 patients(2019)2 cited